395 related articles for article (PubMed ID: 18194706)
41. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up.
Murphy DG; Kerger M; Crowe H; Peters JS; Costello AJ
Eur Urol; 2009 Jun; 55(6):1358-66. PubMed ID: 19147274
[TBL] [Abstract][Full Text] [Related]
42. Focal prostate cryoablation: initial results show cancer control and potency preservation.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
[TBL] [Abstract][Full Text] [Related]
43. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer.
Stolzenburg JU; Bynens B; Do M; Rabenalt R; Katsakiori PF; Liatsikos E
Urology; 2007 Nov; 70(5):956-60. PubMed ID: 17919699
[TBL] [Abstract][Full Text] [Related]
44. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
Ho SF; Lao HF; Li K; Tse MK
Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
[TBL] [Abstract][Full Text] [Related]
45. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
47. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
Frattaroli J; Weidner G; Dnistrian AM; Kemp C; Daubenmier JJ; Marlin RO; Crutchfield L; Yglecias L; Carroll PR; Ornish D
Urology; 2008 Dec; 72(6):1319-23. PubMed ID: 18602144
[TBL] [Abstract][Full Text] [Related]
48. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review.
Onik G
Technol Cancer Res Treat; 2004 Aug; 3(4):365-70. PubMed ID: 15270587
[TBL] [Abstract][Full Text] [Related]
49. Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
Pelzer AE; Colleselli D; Bektic J; Steiner E; Ramoner R; Mitterberger M; Schwentner C; Schaefer G; Ongarello S; Bartsch G; Horninger W
BJU Int; 2008 Apr; 101(7):822-5. PubMed ID: 18261154
[TBL] [Abstract][Full Text] [Related]
50. Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.
Mann MJ; DeCastro GJ; Desai M; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1203-7. PubMed ID: 18674807
[TBL] [Abstract][Full Text] [Related]
51. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537
[TBL] [Abstract][Full Text] [Related]
52. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F
Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578
[TBL] [Abstract][Full Text] [Related]
53. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
54. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
55. Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair.
Thomas AA; Rosenblatt S; Wachterman J; Liao W; Moussa A; Ponsky LE; Jones JS
J Am Coll Surg; 2009 Sep; 209(3):371-6. PubMed ID: 19717042
[TBL] [Abstract][Full Text] [Related]
56. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency.
Onik G; Narayan P; Vaughan D; Dineen M; Brunelle R
Urology; 2002 Jul; 60(1):109-14. PubMed ID: 12100934
[TBL] [Abstract][Full Text] [Related]
57. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M
BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
[TBL] [Abstract][Full Text] [Related]
58. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.
Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO
BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132
[TBL] [Abstract][Full Text] [Related]
59. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
[TBL] [Abstract][Full Text] [Related]
60. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?
Godoy G; Tareen BU; Lepor H
Urology; 2009 Jul; 74(1):167-70. PubMed ID: 19406457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
